VTR
43
-3
FMC
37
-2
SCHW
53
-11
EXPD
37
-2
BIIB
38
-2
PGR
59
5
KHC
22
2
ZION
57
-3
UNP
43
3
EW
53
-2
NKE
37
-3
INTU
59
-3
T
48
3
AVB
57
-2
HIG
51
3
SIG
54
2
LEN
45
3
DNB
58
2
KO
44
-2
BK
66
-2
VTR
43
-3
FMC
37
-2
SCHW
53
-11
EXPD
37
-2
BIIB
38
-2
PGR
59
5
KHC
22
2
ZION
57
-3
UNP
43
3
EW
53
-2
NKE
37
-3
INTU
59
-3
T
48
3
AVB
57
-2
HIG
51
3
SIG
54
2
LEN
45
3
DNB
58
2
KO
44
-2
BK
66
-2
Financhill
Back

AbbVie Vs. Cytokinetics Industry Stock Comparison

Sell
40

ABBV
AbbVie

Last Price:
173.36
Seasonality Move:
3.38%
Sell
48

CYTK
Cytokinetics

Last Price:
48.66
Seasonality Move:
10.93%
Sell
40
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $173.37. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $48.65. The Score for CYTK is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $173.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $48.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.72 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: -1046334 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (168.49 - 182.61) Sell
Bollinger Bands (100): (179.27 - 198.19) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.83 Sell
Relative Strength Index (14 RSI): 38.54 Sell
Chaikin Money Flow: -735707 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.04 - 54.5) Sell
Bollinger Bands (100): (51.46 - 56.82) Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 175.25 Sell
20-day SMA: 175.19 Sell
50-day SMA: 184.96 Sell
200-day SMA: 178.92 Sell
8-day EMA: 175.26 Sell
20-day EMA: 177.49 Sell
50-day EMA: 182.23 Sell
200-day EMA: 178.46 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.3 Sell
20-day SMA: 50.54 Sell
50-day SMA: 52.76 Sell
200-day SMA: 57.64 Sell
8-day EMA: 50.2 Sell
20-day EMA: 51 Sell
50-day EMA: 52.31 Sell
200-day EMA: 54.72 Sell

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.23 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $0.04 per share.

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):